Europe & Central Asia vs Japan: Survival to age 65, female
Europe & Central Asia
90.0%
in 2024
Japan
94.9%
in 2024
Europe & Central Asia rank
6th
Japan rank
8th
Survival to age 65, female over time
- Europe & Central Asia
- Japan
How they compare
Japan currently reports 94.9% against 90.0% in Europe & Central Asia, a difference of 4.9%.
That makes Japan's figure about 1.1 times Europe & Central Asia's.
The two have swapped places 1 time across 65 shared years of data; in 1960 it was Europe & Central Asia ahead.
Europe & Central Asia ranks 6th and Japan ranks 8th of 47 groups.
Japan has averaged higher in every one of the 7 decades both report.
Head to head by decade
| Decade | Europe & Central Asia | Japan | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 78.5% | 79.3% | 0.8% | Japan |
| 1970s | 80.6% | 85.8% | 5.1% | Japan |
| 1980s | 82.7% | 90.0% | 7.3% | Japan |
| 1990s | 83.6% | 91.8% | 8.2% | Japan |
| 2000s | 85.3% | 93.1% | 7.8% | Japan |
| 2010s | 88.3% | 94.0% | 5.8% | Japan |
| 2020s | 88.9% | 94.6% | 5.8% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, female, Europe & Central Asia or Japan?
- Japan, at 94.9% against 90.0% in Europe & Central Asia as of 2024.
- What is the difference in survival to age 65, female between Europe & Central Asia and Japan?
- 4.9%, with Japan ahead.
- How many years of comparable data are there for Europe & Central Asia and Japan?
- 65 years are reported by both, from 1960 to 2024.
- How do Europe & Central Asia and Japan rank globally for survival to age 65, female?
- Europe & Central Asia ranks 6th and Japan ranks 8th of 47 groups.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, female (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.